Venetoclax Combination with Hypomethylating Agents for Treatment of Myelodysplastic Syndromes

Najla Al Ali,David Sallman,Rebecca Nelson,Chetasi Talati,Andrew Kuykendall,Kendra Sweet,Eric Padron,Jeffrey Lancet,Alan List,Rami Komrokji

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2019）

引用 0|浏览12

暂无评分

摘要

Venetoclax (VEN) addition to hypomethylating agents (HMA) has emerged as a new standard therapy for older AML patients (pts). We present preliminary data using VEN/HMA in Myelodysplastic syndromes (MDS) pts.

查看译文

关键词

venetoclax,MDS,hypomethylating agents,myelodysplastic syndromes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要